Neurol. praxi. 2022;23(1):18-23 | DOI: 10.36290/neu.2021.070

Congenital muscular dystrophies

MUDr. Ondřej Havlín, MUDr. Zdenka Bálintová, MUDr. Lenka Juříková, doc. MUDr. Hana Ošlejšková, Ph.D.
Klinika dětské neurologie LF MU a FN Brno

From a historical definition, congenital muscular dystrophies are a heterogenous group of muscle disorders characterized by early-onset muscle disease with histopathological evidence of a dystrophic process. Recent progress of molecular genetics has changed the perspective of the entire group. Continuous deciphering of the genetic background and increasing number of genetically confirmed cases highlights a significant genetic and clinical heterogenicity and makes former clinico-histopathological classifications less useful. It also blurs the classification barriers between congenital muscular dystrophies, limb girdle muscular dystrophies and congenital myopathies groups as they share and overlap at clinical, morphological and genetic level. This text provides a brief summary of the current knowledge accompanied by clinical vignettes from the clinical practice.

Keywords: congenital muscular dystrophy, primary merosin deficiency, collagen VI - related dystrophies, dystroglycanopathies.

Received: July 27, 2021; Revised: September 13, 2021; Accepted: September 15, 2021; Prepublished online: September 15, 2021; Published: March 14, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Havlín O, Bálintová Z, Juříková L, Ošlejšková H. Congenital muscular dystrophies. Neurol. praxi. 2022;23(1):18-23. doi: 10.36290/neu.2021.070.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alberts, et al. Molecular Biology of the Cell. Garland Science, 2007, 5th ed.
    2. Arbogast S, Ferreiro A. Selenoproteins and protection against oxidative stress: selenoprotein N as a novel player at the crossroads of redox signaling and calcium homeostasis. Antioxid Redox Signal. 2010;12(7):893-904. doi: 10.1089/ars.2009.2890. Go to original source... Go to PubMed...
    3. Baker NL, Mörgelin M, Peat R, et al. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Hum Mol Genet. 2005;14(2):279-293. doi: 10.1093/hmg/ddi025. Epub 2004 Nov 24. Go to original source... Go to PubMed...
    4. Bönnemann CG. The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy. Handb Clin Neurol. 2011;101:81-96. doi: 10.1016/B978-0-08-045031-5.00005-0. Go to original source... Go to PubMed...
    5. Bönnemann CG, Wang CH, Quijano-Roy S, et al. Members of International Standard of Care Committee for Congenital Muscular Dystrophies. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord. 2014;24(4):289-311. doi: 10.1016/j.nmd.2013.12.011. Epub 2014 Jan 9. Go to original source... Go to PubMed...
    6. Burke, B, Stewart CL. Life at the edge: the nuclear envelope and human disease. Nat Rev Mol Cell Biol. 2002;3:575-585. Go to original source... Go to PubMed...
    7. Clement EM, Feng L, Mein R, et al. Relative frequency of congenital muscular dystrophy subtypes: analysis of the UK diagnostic service 2001-2008. Neuromuscul Disord. 2012;22:5227. Go to original source... Go to PubMed...
    8. Cormand B, Pihko H, Bayés M, et al. Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology. 200124;56(8):1059-1069. doi: 10.1212/wnl.56.8.1059. Go to original source... Go to PubMed...
    9. D'Amico A, Haliloglu G, Richard P, et al. Two patients with "Dropped head syndrome" due to mutations in LMNA or SEPN1 genes. Neuromuscul Disord. 2005;15(8):521-524. doi: 10.1016/j.nmd.2005.03.006. Go to original source... Go to PubMed...
    10. D'Amico A, Haliloglu G, Richard, et al. Two patients with "dropped head syndrome" due to mutations in LMNA or SEPN1 genes. Neuromusc Disord 2005;15:521-524. Go to original source... Go to PubMed...
    11. Flanigan KM, Kerr L, Bromberg MB, et al. Congenital muscular dystrophy with rigid spine syndrome: a clinical, pathological, radiological, and genetic study. Ann Neurol. 2000;47(2):152-161. PMID: 10665485. Go to original source...
    12. Fukuyama, Y, Haruna H. A peculiar form of congenital progressive muscular dystrophy: report of fifteen cases. Paediat Univ Tokyo. 1960;4:5-8.
    13. Geranmayeh F, Clement E, Feng LH, et al. Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. Neuromuscul Disord. 2010;20(4):241-250. doi: 10.1016/j.nmd.2010.02.001. Epub 2010 Mar 6. Go to original source... Go to PubMed...
    14. Godfrey C, Clement E, Mein R, et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain. 2007;130(Pt 10):2725-2735. doi: 10.1093/brain/awm212. Epub 2007 Sep 18. Go to original source... Go to PubMed...
    15. Havlin O, Jurikova L. Kongenitální svalové dystrofie. Postgraduální medicína. 2019;21(3):242-246.
    16. Hicks D, Lampe AK, Barresi R, et al. A refined diagnostic algorithm for Bethlem myopathy. Neurology. 2008;70(14):1192-1199. doi: 10.1212/01.wnl.0000307749.66438.6d. Go to original source... Go to PubMed...
    17. Mah JK, Korngut L, Fiest KM, et al. A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies. Can J Neurol Sci. 2016;43(1):163-177. doi: 10.1017/cjn.2015.311. Go to original source... Go to PubMed...
    18. Michele DE, Campbell KP. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J Biol Chem. 2003;278:15457-15460. Go to original source... Go to PubMed...
    19. Murakami T, Hayashi YK, Noguchi S, et al. Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol. 2006;60(5):597-602. doi: 10.1002/ana.20973. Go to original source... Go to PubMed...
    20. Nadeau A, Kinali M, Main M, et al. Natural history of Ullrich congenital muscular dystrophy. Neurology. 2009;73(1):25-31. doi: 10.1212/WNL.0b013e3181aae851. Go to original source... Go to PubMed...
    21. Philpot J, Cowan F, Pennock J, et al. Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging. Neuromuscul Disord. 1999;9(2):81-85. doi: 10.1016/s0960-8966(98)00110-2. Go to original source... Go to PubMed...
    22. Poppe M, Bourke J, Eagle M, et al. Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol. 2004;56(5):738-741. doi: 10.1002/ana.20283. Go to original source... Go to PubMed...
    23. Quijano-Roy S, Mbieleu B, Bönnemann CG, et al. De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann Neurol. 2008;64(2):177-186. doi: 10.1002/ana.21417. Go to original source... Go to PubMed...
    24. Schorling DC, Kirschner J, Bönnemann CG. Congenital Muscular Dystrophies and Myopathies: An Overview and Update. Neuropediatrics. 2017;48(4):247-261. doi: 10.1055/s-0037-1604154. Epub 2017 Jul 2. Go to original source... Go to PubMed...
    25. Shorer Z, Philpot J, Muntoni F, et al. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy. J Child Neurol. 1995;10(6):472-475. doi: 10.1177/088307389501000610. Go to original source... Go to PubMed...
    26. Straub V, Murphy A, Udd B; LGMD workshop study group. 229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017. Neuromuscul Disord. 2018;28(8):702-710. doi: 10.1016/j.nmd.2018.05.007. Epub 2018 May 24. Go to original source... Go to PubMed...
    27. Villar-Quiles RN, von der Hagen M, Métay C, et al. The clini­cal, histologic, and genotypic spectrum of SEPN1-related myopathy: A case series. Neurology. 2020;95(11):e1512-e1527. doi: 10.1212/WNL.0000000000010327. Epub 2020 Aug 13. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.